Get MindMed Updates:

JR Rahn
Chief Executive Officer, Board Director, & Co-Founder


Dr. Miri Halperin Wernli
Executive President; Board Director; Chair of Technology Evaluation, Acquisition and Scientific Integrity Board Committee


Robert Barrow
Chief Development Officer


Carol Nast
Chief Operating Officer


Donald Gehlert, PhD
Chief Scientific Officer


Dave Guebert
Chief Financial Officer


Jeanne Bonelle
EVP, Technical Operations


Shahera St. John
VP, Programs


Nico Forte
Senior Director, Business Operations and Development


Carole Abel
Senior Director Clinical Operations & Program Leader LSD


Madeline Feldman
Director of Operations & Administration


Collin Gage
Vice President of Corporate Development


Rachann McKnight
Director, Business Process


Jon Polaha
Financial Analyst


Stanley D. Glick, PhD, MD
Scientific Advisor


Natalie Wheeler, PhD
Medical Science Liaison with Dova Pharmaceuticals


Matthew W. Johnson, Ph.D
Clinical Advisor


Kenneth Alper, MD
Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine


Dr. Peter Gasser
Clinical Advisor


Sarah McCallum, PhD
Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College


John Rotrosen, MD
Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry


Professor Dr. Matthias Liechti, PhD & M.D.
Scientific Collaborator & Advisor


Dr. Kim Kuypers
Scientific Collaborator & Advisor


Brigid Makes
Board Director, Chair of Audit Commitee, Member of Compensation, Nomination and Governance Committee


Perry Dellelce
Chairman, Member of Audit and Compensation, Nomination and Governance Committees


Bruce Linton
Board Director, Chair of Compensation, Nomination and Governance Committee, Member of Audit Committee


Stephen L. Hurst, JD
Co-Founder and Board Director


Scott Freeman, MD
Co-Founder & Clinical Advisor


Leonard Latchman
Co-Founder
